Antibody validation
Top Cited Papers
Open Access
- 28 February 2010
- journal article
- review article
- Published by Taylor & Francis Ltd in BioTechniques
- Vol. 48 (3), 197-209
- https://doi.org/10.2144/000113382
Abstract
Antibodies are among the most frequently used tools in basic science research and in clinical assays, but there are no universally accepted guidelines or standardized methods for determining the validity of these reagents. Furthermore, for commercially available antibodies, it is clear that what is on the label does not necessarily correspond to what is in the tube. To validate an antibody, it must be shown to be specific, selective, and reproducible in the context for which it is to be used. In this review, we highlight the common pitfalls when working with antibodies, common practices for validating antibodies, and levels of commercial antibody validation for seven vendors. Finally, we share our algorithm for antibody validation for immunohistochemistry and quantitative immunofluorescence.This publication has 45 references indexed in Scilit:
- The Dark Side of the Immunohistochemical Moon: IndustryJournal of Histochemistry & Cytochemistry, 2009
- Validation of the 4B5 rabbit monoclonal antibody in determining Her2/neu status in breast cancerLaboratory Investigation, 2009
- Immunohistochemical validation of multiple phospho-specific epitopes for estrogen receptor α (ERα) in tissue microarrays of ERα positive human breast carcinomasBreast Cancer Research and Treatment, 2008
- Commercial Antibodies: The Good, Bad, and Really UglyJournal of Histochemistry & Cytochemistry, 2008
- Immunohistochemical assessment of protein phosphorylation state: the dream and the realityHistochemistry and Cell Biology, 2008
- Antibody-based Validation of CNS Ion Channel Drug TargetsThe Journal of general physiology, 2008
- HER2+ Breast CancerAmerican Journal of Clinical Pathology, 2008
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast CancerJournal of Clinical Oncology, 2007
- REporting recommendations for tumor MARKer prognostic studies (REMARK)Breast Cancer Research and Treatment, 2006
- Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complexCancer Cell, 2004